| Fiscal period | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|
| Period End Date | 5/31/2022 | 5/31/2021 | 5/31/2020 | 5/31/2019 | 5/31/2018 | 5/31/2017 | 5/31/2016 | 5/31/2015 | 5/31/2014 | 5/31/2013 |
|---|
| Sales | 316.22 | 291.01 | 264.16 | 270.63 | 261.66 | 269.79 | 353.89 | 356.53 | 354.43 | 341.92 |
| Total Revenues | 316.22 | 291.01 | 264.16 | 270.63 | 261.66 | 269.79 | 353.89 | 356.53 | 354.43 | 341.92 |
| Cost of sales | 150.49 | 134.22 | 113.89 | 114.63 | 117.80 | 125.84 | 179.57 | 180.74 | 174.25 | 173.40 |
| Gross Profit | 165.73 | 156.79 | 150.27 | 156.00 | 143.86 | 143.95 | 174.32 | 175.80 | 180.17 | 168.51 |
| Goodwill impairment | -- | -- | 158.58 | -- | -- | -- | -- | -- | -- | -- |
| Amortization of intangibles | 19.46 | 18.14 | 18.12 | 17.06 | 13.91 | 14.57 | 17.96 | 17.97 | 16.56 | 16.62 |
| Research and development | 30.74 | 36.39 | 29.68 | 28.26 | 24.34 | 24.15 | 25.05 | 26.59 | 28.12 | 26.32 |
| General and Administrative | 38.45 | 35.92 | 37.87 | 34.90 | 30.99 | 31.13 | 30.58 | 30.03 | 26.90 | 26.19 |
| Sales and marketing | 95.30 | 81.31 | 78.63 | 76.83 | 73.11 | 74.87 | 83.74 | 82.35 | 85.31 | 76.12 |
| Restructuring and other costs, net | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Acquisition and other non-recurring | 9.04 | 20.23 | 6.01 | 15.13 | 15.43 | 27.51 | 12.59 | 26.26 | 10.87 | 13.80 |
| Litigation provisions, net | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Change in fair value of contingent consideration | (1.21) | (0.09) | 11.53 | 6.78 | (0.25) | 15.26 | (0.95) | 8.10 | 1.91 | (1.58) |
| Medical device excise tax | -- | -- | -- | -- | -- | 1.84 | (2.42) | (4.14) | (3.83) | (1.60) |
| Total Operating Expenses | 194.20 | 192.07 | 317.37 | 165.40 | 158.03 | 155.13 | 173.30 | 179.25 | 169.69 | 162.23 |
| Operating Income (Loss) | (28.47) | (35.28) | (167.10) | (9.40) | (14.17) | (11.18) | 1.02 | (3.45) | 10.49 | 6.29 |
| Interest expense | 0.69 | 0.86 | 0.91 | 5.10 | 3.06 | 2.84 | 3.39 | 3.19 | 3.66 | 5.27 |
| Impairment loss on investment | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Interest income | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.10 |
| Other income (loss) | (0.79) | 0.09 | (0.13) | (0.21) | (0.03) | (0.28) | (0.89) | (1.49) | (1.65) | (2.71) |
| Total other (expenses) income, net | (1.48) | (0.77) | (1.04) | (5.31) | (3.09) | (3.12) | (4.27) | (4.68) | (5.30) | (7.88) |
| (Loss) income before income tax provision | (29.95) | (36.05) | (168.14) | (14.70) | (17.26) | (14.30) | (3.25) | (8.13) | 5.19 | (1.59) |
| Deferred | -- | -- | -- | (3.97) | (11.11) | (7.65) | 39.98 | (5.12) | 2.72 | 0.83 |
| Income tax (benefit) provision | (3.40) | (4.50) | (1.35) | (3.56) | (11.04) | (7.24) | 40.34 | (4.74) | 2.84 | (0.38) |
| Current : Federal | -- | -- | -- | -- | (0.15) | -- | 0.03 | (0.24) | (0.13) | (1.62) |
| Current : State and local | 0.12 | 0.10 | 0.10 | 0.13 | 0.15 | 0.14 | 0.10 | 0.21 | 0.10 | (0.05) |
| Current : Non U.S | 0.19 | 0.20 | 0.12 | 0.29 | 0.07 | 0.27 | 0.22 | 0.42 | 0.16 | 0.47 |
| Deferred- U.S | (3.42) | (3.38) | (1.12) | -- | -- | -- | -- | -- | -- | -- |
| Deferred- Non U.S | (0.29) | (1.43) | (0.45) | -- | -- | -- | -- | -- | -- | -- |
| Net income (loss) from continuing operations | -- | -- | -- | (11.15) | (6.23) | (7.05) | -- | -- | -- | -- |
| Income from discontinued operations, net of income tax | -- | -- | -- | 72.49 | 22.56 | 12.06 | -- | -- | -- | -- |
| Net income available to Common Shareholders | (26.55) | (31.55) | (166.79) | 61.34 | 16.34 | 5.01 | (43.59) | (3.39) | 2.35 | (1.21) |
| Basic Earnings (Loss) Per Share From Continuing Operations | -- | -- | -- | (0.30) | (0.17) | (0.19) | -- | -- | -- | -- |
| Basic Earnings per Share from Discontinued Operations | -- | -- | -- | 1.93 | 0.61 | 0.33 | -- | -- | -- | -- |
| Net Earnings Per Share (Basic) | (0.68) | (0.82) | (4.39) | 1.64 | 0.44 | 0.14 | (1.21) | (0.09) | 0.07 | (0.03) |
| Diluted Earnings (Loss) Per Share From Continuing Operations | -- | -- | -- | (0.30) | (0.17) | (0.19) | -- | -- | -- | -- |
| Diluted Earnings per Share from Discontinued Operations | -- | -- | -- | 1.93 | 0.61 | 0.33 | -- | -- | -- | -- |
| Net Earnings Per Share (Diluted) | (0.68) | (0.82) | (4.39) | 1.64 | 0.44 | 0.14 | (1.21) | (0.09) | 0.07 | (0.03) |
| Weighted Average Shares Outstanding (Basic) | 39.01 | 38.34 | 37.96 | 37.49 | 37.08 | 36.62 | 36.16 | 35.68 | 35.14 | 34.82 |
| Weighted Average Shares Outstanding (Diluted) | 39.01 | 38.34 | 37.96 | 37.49 | 37.08 | 36.62 | 36.16 | 35.68 | 35.44 | 34.82 |